Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$0.18 - $0.86 $1,671 - $7,984
9,284 Added 6.32%
156,139 $41,000
Q1 2022

May 04, 2022

BUY
$0.6 - $1.06 $12,837 - $22,679
21,396 Added 17.05%
146,855 $88,000
Q3 2021

Nov 05, 2021

BUY
$1.33 - $1.77 $293 - $391
221 Added 0.18%
125,459 $167,000
Q2 2021

Aug 02, 2021

BUY
$1.41 - $1.94 $14,476 - $19,917
10,267 Added 8.93%
125,238 $180,000
Q1 2021

May 13, 2021

BUY
$1.61 - $2.77 $33,075 - $56,906
20,544 Added 21.76%
114,971 $207,000
Q4 2020

Feb 10, 2021

BUY
$1.55 - $2.24 $14,182 - $20,496
9,150 Added 10.73%
94,427 $165,000
Q3 2020

Nov 12, 2020

BUY
$1.91 - $3.08 $8,117 - $13,090
4,250 Added 5.25%
85,277 $166,000
Q2 2020

Aug 14, 2020

SELL
$1.97 - $3.98 $1,487 - $3,004
-755 Reduced 0.92%
81,027 $224,000
Q1 2020

May 18, 2020

BUY
$1.17 - $3.0 $95,684 - $245,346
81,782 New
81,782 $245,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.